Pelthos Therapeutics Inc. (PTHS) vs Rallybio Corporation (RLYB)
Pelthos Therapeutics Inc. and Rallybio Corporation are both Biotechnology companies. Pelthos Therapeutics Inc. and Rallybio Corporation are of similar size ($88.2M and $85.8M). Pelthos Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Rallybio Corporation has the higher net margin (0.00% vs −199.5%) and the lower return on invested capital (−1,052.0% vs −82.3%). Across the 15 metrics below, Rallybio Corporation leads on 10 and Pelthos Therapeutics Inc. on 5.
Valuation
Profitability
| Metric | PTHS | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.59% | 100.00% | 65.16% |
| Operating margin | (133.42%) | 0.00% | 0.00% |
| Net margin | (199.50%) | 0.00% | 0.00% |
| Free cash flow margin | (98.37%) | 0.00% | 0.00% |
| Return on equity | 2,161.07% | 64.86% | (57.72%) |
| Return on assets | (125.04%) | 61.12% | (49.22%) |
| Return on invested capital | (82.34%) | (1,052.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack